U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H5O5P
Molecular Weight 140.0319
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHOSPHONOACETIC ACID

SMILES

OC(=O)CP(O)(O)=O

InChI

InChIKey=XUYJLQHKOGNDPB-UHFFFAOYSA-N
InChI=1S/C2H5O5P/c3-2(4)1-8(5,6)7/h1H2,(H,3,4)(H2,5,6,7)

HIDE SMILES / InChI

Molecular Formula C2H5O5P
Molecular Weight 140.0319
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Fosfonet sodium (or phosphonoacetate sodium), an organophosphorus compound, was found to be a specific inhibitor of the virus-induced DNA polymerases and thus could inhibit specifically the replication of herpes-viruses.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P04293
Gene ID: 2703462.0
Gene Symbol: NA
Target Organism: Human herpesvirus 1 (strain 17) (HHV-1) (Human herpes simplex virus|||1)
PubMed

PubMed

TitleDatePubMed
Autophagy suppresses tumor progression by limiting chromosomal instability.
2007-06-01
Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection.
2007-04-04
Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.
2007-04-01
Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts.
2007-03
Enriching suicide gene bearing tumor cells for an increased bystander effect.
2007-01
Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells.
2007-01
Phosphonoacetic acid utilization by fungal isolates: occurrence and properties of a phosphonoacetate hydrolase in some penicillia.
2006-12
Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors.
2006-12
Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
2006-11
N-phosphonacetyl-L-isoasparagine a potent and specific inhibitor of Escherichia coli aspartate transcarbamoylase.
2006-10-05
Picosecond dynamics of T and R forms of aspartate transcarbamylase: a neutron scattering study.
2006-10
Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate.
2006-09-22
Alpha-herpesvirus infection induces the formation of nuclear actin filaments.
2006-08
A role for carbon catabolite repression in the metabolism of phosphonoacetate by Agromyces fucosus Vs2.
2006-08
Development of a common fully stereocontrolled access to the medicinally important and promising prostacyclin analogues iloprost, 3-oxa-iloprost and cicaprost.
2006-07-17
Fully stereocontrolled syntheses of 3-oxacarbacyclin and carbacyclin by the conjugate addition-azoalkene-asymmetric olefination strategy.
2006-06-09
Bond strength to primed Ti-6Al-7Nb alloy of two acrylic resin adhesives.
2006-06
Detection of phosphonoacetate degradation and phnA genes in soil bacteria from distinct geographical origins suggest its possible biogenic origin.
2006-05
Functional annotation and kinetic characterization of PhnO from Salmonella enterica.
2006-03-07
Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases.
2006-03
Phosphonoacetate hydrolase from Penicillium oxalicum: purification and properties, phosphate starvation-independent expression, and partial sequencing.
2006-03
Inhibition of adenosine kinase by phosphonate and bisphosphonate derivatives.
2006-02
Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
2005-12-20
Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice.
2005-12
Functional inaccessibility of quiescent herpes simplex virus genomes.
2005-11-21
Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase.
2005-11
Synthesis of farnesol isomers via a modified Wittig procedure.
2005-10-27
Precursor decomposition and nucleation kinetics during platelike apatite synthesis.
2005-09-15
[Photodynamic inhibition of infection caused by herpes simplex virus type 1 in the cultured cells, by using 5-aminolevulinic acid-induced porphyrins].
2005-08-18
Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity.
2005-08-15
Anion binding and controlled aggregation of human interleukin-1 receptor antagonist.
2005-07-26
Effect of ligand structure on the pathways for iron release from human serum transferrin.
2005-07-11
A single amino acid substitution in the active site of Escherichia coli aspartate transcarbamoylase prevents the allosteric transition.
2005-06-03
Aspartate transcarbamylase from the hyperthermophilic archaeon Pyrococcus abyssi. Insights into cooperative and allosteric mechanisms.
2005-06
Sensitivity to phosphonoacetic acid: a new phenotype to probe DNA polymerase delta in Saccharomyces cerevisiae.
2005-06
Genomic instability in Gadd45a-/- cells is coupled with S-phase checkpoint defects.
2005-05
The antiviral activity of the combinations of netropsin derivatives with modified nucleosides and phosphonoacetic acid as estimated in the model of herpesvirus type 1 in a vero cell culture.
2005-04-26
Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
2005-03
The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system.
2005-02
Phosphonate catabolism by Campylobacter spp.
2005-02
A facile synthesis of novel chiral phosphonoacetates bearing a stereogenic phosphorus atom.
2005-01
Cyclic sulfamidates as vehicles for the synthesis of substituted lactams.
2004-12-09
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
2004-11
Characterization and expression of the pseudorabies virus early gene UL54.
2004-08
Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
2004-07-01
Tetrahedral intermediates in thiamin diphosphate-dependent decarboxylations exist as a 1',4'-imino tautomeric form of the coenzyme, unlike the michaelis complex or the free coenzyme.
2004-06-01
Aspartate transcarbamylase (ATCase) of Escherichia coli: a new crystalline R-state bound to PALA, or to product analogues citrate and phosphate.
2004-06-01
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
2004-03
In vitro antiviral activity of polyoxotungstate (PM-19) and other polyoxometalates against herpes simplex virus.
1991-12
Inhibition of herpes simplex virus replication by phosphonoacetic acid.
1974-09
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:23:47 GMT 2025
Edited
by admin
on Mon Mar 31 18:23:47 GMT 2025
Record UNII
N919E46723
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-18205
Preferred Name English
PHOSPHONOACETIC ACID
Systematic Name English
FOSFONET
Common Name English
PHOSPHONOACETATE
Systematic Name English
Classification Tree Code System Code
WHO-ATC J05AD02
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
NCI_THESAURUS C29575
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
NCI_THESAURUS C281
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
WHO-VATC QJ05AD02
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C84056
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
CAS
4408-78-0
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID2045107
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
SMS_ID
300000044803
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
CHEBI
57488
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
ECHA (EC/EINECS)
224-558-1
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
NSC
18205
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
FDA UNII
N919E46723
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
DRUG BANK
DB02823
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
MESH
D010746
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
CHEBI
15732
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
PUBCHEM
546
Created by admin on Mon Mar 31 18:23:47 GMT 2025 , Edited by admin on Mon Mar 31 18:23:47 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY